Evidence Log
Exhibit Register
Filed documentation supporting the investigative claims.
Exhibit A — Pricing ledger
Quotes collected from online sellers and marketplaces.
| Seller | Claim | Price |
|---|---|---|
| Seller A | “Original Ozempic” | ₦1.5M |
| Seller B | “VIP supply” | ₦5M |
| Seller C | “Hospital grade” | ₦2.2M |
Exhibit B
NAFDAC lookup
No record of Ozempic or semaglutide registered for distribution.
Exhibit C
Victim statements
Accounts describe packaging inconsistencies and lack of verification.
Closing statement
Evidence demonstrates a pattern of misleading claims and unsafe distribution.